Medical Marijuana, Inc.’s CEO Announces Vision for Hemp Industry Revolution in Video Statement

In a video statement, Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. (OTC Pink:MJNA), makes it clear what the Company’s vision and mission is: inspire change. Dr. Titus states, “There are a tremendous amount of industries that are waiting for us to be able to grow hemp here in the U.S. With the American entrepreneurial spirit, I believe this can foster a revolution in our economy.”

The U.S. legal cannabis industry is valued at $2.7 billion and, with full legalization, the projected value is $36.8 billion. Oregon, a state that is reported to have more medical cannabis dispensaries than Starbucks and McDonald’s locations, is the next state to legalize adult recreational use of cannabis. Estimates for both Colorado’s and Washington’s recreational adult use market is $800 million by 2020. One of MJNA’s portfolio brands, MPSI, provides cannabis security services to this rapidly growing industry.

“We will never see a time like this in our lives again,” states Michael Julian, CEO of MPSI, in MJNA’s video statement. “There is no better time than right now to get involved in the cannabis industry.”

Medical Marijuana, Inc. (MJNA) has dedicated years of time and invested millions of dollars to create the world’s largest CBD hemp oil pipeline to all 50 states, territories, and countries around the world. MJNA’s diversified portfolio brands and investments are composed of some of the industry’s leaders that include: HempMeds, Kannaway, MPSI, Dixie Botanicals, AXIM Biotechnologies, Inc., and KannaLife Sciences. The functions of these industry innovators range from hemp-based food, nutraceutical, and pharmaceutical R&D to manufacturing, marketing, and product sales as well as providing cannabis security solutions to businesses serving the industry. All are educating the masses on the importance of hemp to the global environment, economy and daily lives of consumers worldwide.

Hemp is widely regarded a “whole food” and “super food.” When it comes to hemp products, consumers are responding by driving increased popularity. MJNA’s CBD hemp oil is derived from the mature stalk of the hemp plant and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic/euphoric effects of THC. The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market.

From a well-being standpoint Dr. Titus continues, “Ninety percent of disorders that we experience are caused by environmental factors: toxic waters, pollution of the environment. Hemp is used for bioremediation purposes – that means it is basically used to clean up toxic soil. Taking that one step further, imagine if you take hemp inside your body.”

Dr. Titus concludes, “Quite honestly, I’m such a lucky individual at my age to have recaptured as much life and vitality as I have. If I can do that for just one other individual on this planet — give them that hope — that makes all the good effort we do, with late hours that we work, all worthwhile.”

In MJNA’s spirit of inspiring change, for the first time in U.S. history, the Company’s flagship product Real Scientific Hemp Oil(TM) (RSHO(TM)) has been the catalyst for global cannabis law change. It is being allowed for import into Brazil with special documentation.

For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit To see Medical Marijuana, Inc.’s video statement, click here.

About Medical Marijuana, Inc.

Our mission is to be the premier hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at:


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The Company does grow, sell and distribute hemp-based products and are involved with the federally legal distribution of hemp-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


For further information, please contact:
Public Relations contact:
Andrew Hard
CMW Media
P. 858-380-5478
Corporate contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
Investor Relations:
GH Investment Advisors
550 West “C” Street, Ste. 2040
San Diego, CA 92101
Nick Massalas
Office: (858) 264-6500
Toll Free: (877) 964-6463

Comments are closed.

Get the latest content first.
©Marijuana Stocks Report